stockrowiRhythm Holdings, Inc.
IRTC Healthcare Medical Devices
iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.
- Revenue
- +14.9%
- EPS
- −462.5%
- Free cash flow
- −157.6%
- Total debt
- +0.48%
Quarter to September 2026, against a year earlier
Follow IRTC
Alert me
iRhythm Holdings, Inc. (IRTC) Book value per share
iRhythm Holdings, Inc.'s book value per share at the end of fiscal 2025 was 4.8×, up 63.8% from 2.9× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 5.4×. Over the past ten years it has ranged from −3.3× (fiscal 2015) to 17.5× (fiscal 2016); the current reading is higher than 45% of that period. iRhythm Holdings, Inc. ranks 52nd of 149 Medical Devices companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 4.8× | 63.78% |
| FY2024 | 2.9× | (57.66%) |
| FY2023 | 6.9× | (14.15%) |
| FY2022 | 8.0× | (15.88%) |
| FY2021 | 9.5× | (22.58%) |
| FY2020 | 12.3× | 129.67% |
| FY2019 | 5.4× | 145.54% |
| FY2018 | 2.2× | (37.92%) |
| FY2017 | 3.5× | (79.92%) |
| FY2016 | 17.5× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 5.4× | (5.36%) |
| Jun 2026 | 5.7× | 14.01% |
| Mar 2026 | 5.0× | 3.91% |
| Dec 2025 | 4.8× | 25.96% |
| 41 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| UFPT UFP Technologies, Inc. compare | 62.7× |
| ITGR Integer Holdings Corporation compare | 50.7× |
| LIVN LivaNova PLC compare | 24.9× |
| HAE Haemonetics Corporation compare | 19.7× |
| TMDX TransMedics Group, Inc. compare | 15.9× |
| NEOG Neogen Corporation compare | 9.6× |
| AXGN AxoGen, Inc. compare | 9.0× |
| TXG 10x Genomics compare | 6.4× |
| IRTC iRhythm Holdings, Inc. | 5.4× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on IRTC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement